Skip to main content

Abivax S.A.

ABVX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001956827

No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.

Other share classesAAVXF

Members of Congress who traded ABVX

No member of Congress has reported a trade in Abivax S.A. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.